Sarah Le Merdy is Systems and Single-Use Global Strategy Deployment Manager at Life Science business of Merck KgaA, Darmstadt, Germany.
A Step Closer to Closure in Bioprocessing
As biopharma anticipates the “Facility of the Future,” a definition of what closed processing is, and quantification of its value, can be helpful information.
Perceptions and Considerations for Adopting Closed Processing
The combination of modular facilities and closed processing offers significant advantages in the production of biopharmaceuticals and is becoming a compelling option for manufacturing.